Growth hormone and renal osteodystrophy: a case report.
A 14-year-old male with end-stage renal disease on hemodialysis was treated with recombinant growth hormone for growth retardation. He developed severe renal osteodystrophy, which responded only to the discontinuation of growth hormone.
Kaufman
D B
DB
Michigan State University, College of Human Medicine, Department of Pediatrics/Human Development, East Lansing 48824-1317, USA.
D000293:Adolescent; D002118:Calcium / Q000097:blood; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000139:chemically induced* / Q000473:pathology; D006130:Growth Disorders / Q000188:drug therapy / Q000209:etiology; D013006:Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects
D010281:Parathyroid Hormone; D010710:Phosphates; D013006:Growth Hormone; D002118:Calcium